Sexual inactivity and dyspareunia remained common after cervical radio(chemo)therapy
Sexual inactivity reached 49% and dyspareunia 54% after cervical radio(chemo)therapy, with fatigue central to broader survivorship impairment.
Tag
quality-of-life
Patients with documented fatigue were less likely to complete electronic symptom surveys after breast RT
Patients with clinician-documented fatigue had 39% lower odds of completing electronic fatigue assessments, exposing an important limitation of PRO-only monitoring.
Oligometastatic survivorship is outgrowing traditional oncology follow-up models
Longer survival after metastasis-directed therapy is creating unmet physical, psychological and functional needs that conventional surveillance pathways may not adequately address.
Poor sleep and fatigue were common after head and neck radiotherapy
Poor sleep affected 69% of survivors, while 21.4% screened as high risk for obstructive sleep apnoea.
Nationwide play-based programme helped children engage with paediatric radiotherapy
The programme prepared 256 children for radiotherapy and was associated with avoidance of daily general anaesthesia in five selected cases.
Early neuropsychological care did not improve three-month quality of life in brain metastases
ATHENA did not improve FACT-Br scores at three months, although an exploratory nine-month analysis favoured neuropsychological integration.
Low-dose radiotherapy produced durable benefit in refractory plantar fasciitis
Low-dose radiotherapy produced sustained pain, function and quality-of-life improvement after conservative treatment and shock-wave therapy had failed.
Postoperative radiotherapy provided better quality of life and value in oral cavity cancer
Postoperative conventional radiotherapy caused fewer head-and-neck symptoms and dominated preoperative accelerated radiotherapy in the five-year cost-utility analysis.
Body composition adds little to radiotherapy toxicity prediction
Computed tomography-derived muscle measures ranked highly for toxicity and quality of life, but added little predictive value beyond established clinical factors.
Cosmesis reporting after radiotherapy for non-melanoma skin cancer remains inconsistent
Most studies used heterogeneous, poorly reproducible cosmetic assessment methods, limiting comparisons between radiotherapy techniques and supporting development of a validated standard.
Dose de-escalation improved patient-reported outcomes in early p16-positive oropharyngeal cancer
Reducing radiotherapy from 70 Gy to 60 Gy was associated with better one-year swallowing outcomes and lower acute toxicity in selected patients.
Quality of life remains impaired after chemoradiotherapy for anal squamous cell carcinoma
Patients reported persistently worse quality of life and functioning approximately two years after chemoradiotherapy than matched individuals without cancer.